TNXP stock closed Friday, July 23, 2021 at $0.98. Earlier in the morning session on Monday, TNXP shares lost 34.18% at $0.64. Tonix Pharmaceuticals Holding
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biotech company, earlier announced that in the Phase 3 RELIEF trial, TNX-102 SL (cyclobenzaprine HCl sublingual tablets)
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.